Behavioral Relaxation Approaches for the Treatment of Insomnia in Lung Cancer Patients

This clinical trial tests whether behavioral relaxation approaches (assisted relaxation therapy and guided compassion meditation) work to reduce insomnia in lung cancer patients. Assisted relaxation therapy may improve insomnia and sleep quality. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Assisted relaxation therapy and guided compassion meditation may help effectively improve sleep disturbances.

Inclusion Criteria

Lung cancer patients 18+ who have insomnia symptoms, have access to a smartphone, and are more than 4 weeks post surgery

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04318249.

PRIMARY OBJECTIVE:

I. To compare the effects of assisted relaxation therapy (ART) only arm to the ART + guided compassion meditation arm in lung cancer patients who experience insomnia symptoms.

OUTLINE: Patients are randomized into 1 of 2 arms.

ARM I: Patients undergo ART nightly for 14 days.

ARM II: Patients undergo ART and guided compassion meditation nightly for 14 days.

Trial PhaseNo phase specified

Trial Typetreatment

Lead OrganizationUniversity of Pennsylvania/Abramson Cancer Center

Principal InvestigatorNalaka S. Gooneratne

Primary IDUPCC 15521
Secondary IDsNCI-2021-12713
ClinicalTrials.gov IDNCT04318249

Behavioral Relaxation Approaches for the Treatment of Insomnia in Lung Cancer Patients

Inclusion Criteria

Have a question?
We're here to help

Which trials are right for you?

Behavioral Relaxation Approaches for the Treatment of Insomnia in Lung Cancer Patients

Description

Eligibility Criteria

Locations & Contacts

Trial Objectives and Outline

Trial Phase & Type

Lead Organization

Trial IDs

Have a question?We're here to help

Which trials are right for you?

Have a question?
We're here to help